Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Exubera – Inhaled Insulin

Drug (Brand/Generic)

Exubera

Company/Licensee

Aventis and Pfizer

Therapy Class

Rapid-acting insulin

Product Description

Inhaled insulin preparation

Current Indication

Insulin-treated diabetes

Market Sector

Diabetes

Development Status

Product withdrawn in October 2007
Expand

Go Top